PARIS, December 8 /PRNewswire/ --
- Not Intended for Media in France
PARIS, December 8 /PRNewswire/ --
- Patients Treated With Protelos Could be Better Protected Than With Alendronate
PARIS, December 8 /PRNewswire/ --
The osteoporosis treatment Protelos(R) (strontium ranelate) significantly improved bone structure in postmenopausal women when compared to the bisphosphonate alendronate according to the results of the first head-to-head study of the two drugs(1) recently released in Osteoporosis International, the official journal of the World Congress of Osteoporosis.